MISCHELLE MORGAN: Open Payments
NPI 1811666316 · RENSSELAER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 23 payments from 10 companies in 2025. Trend: 2023 $553 · 2024 $432 · 2025 $504
Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $150 |
| Exact Sciences Corporation | 4 | $78 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Novo Nordisk Inc | 2 | $43 |
| Lilly USA, LLC | 2 | $39 |
| ABBVIE INC. | 2 | $39 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Edwards Lifesciences Corporation | 1 | $20 |
| Organon LLC | 1 | $12 |
Products named: AIRSUPRA, The Cologuard Plus Collection Kit, SHINGRIX, Wegovy, FARXIGA, NEFFY, REXULTI, SYNTHROID.
Industry payments across NY — which companies pay providers there.
